Global Epigenetics Drugs and Diagnostic Technologies Market Research Report 2023

Report ID: 1991137 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Epigenetics Drugs and Diagnostic Technologies Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 HDAC inhibitors
        1.2.3 DNMT inhibitors
    1.3 Market by Application
        1.3.1 Global Epigenetics Drugs and Diagnostic Technologies Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Non coding RNA’s
        1.3.3 Micro RNA’s
        1.3.4 Histone modifications
        1.3.5 DNA methylation
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Epigenetics Drugs and Diagnostic Technologies Market Perspective (2017-2028)
    2.2 Epigenetics Drugs and Diagnostic Technologies Growth Trends by Region
        2.2.1 Epigenetics Drugs and Diagnostic Technologies Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Epigenetics Drugs and Diagnostic Technologies Historic Market Size by Region (2017-2022)
        2.2.3 Epigenetics Drugs and Diagnostic Technologies Forecasted Market Size by Region (2023-2028)
    2.3 Epigenetics Drugs and Diagnostic Technologies Market Dynamics
        2.3.1 Epigenetics Drugs and Diagnostic Technologies Industry Trends
        2.3.2 Epigenetics Drugs and Diagnostic Technologies Market Drivers
        2.3.3 Epigenetics Drugs and Diagnostic Technologies Market Challenges
        2.3.4 Epigenetics Drugs and Diagnostic Technologies Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Epigenetics Drugs and Diagnostic Technologies Players by Revenue
        3.1.1 Global Top Epigenetics Drugs and Diagnostic Technologies Players by Revenue (2017-2022)
        3.1.2 Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share by Players (2017-2022)
    3.2 Global Epigenetics Drugs and Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Epigenetics Drugs and Diagnostic Technologies Revenue
    3.4 Global Epigenetics Drugs and Diagnostic Technologies Market Concentration Ratio
        3.4.1 Global Epigenetics Drugs and Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Epigenetics Drugs and Diagnostic Technologies Revenue in 2021
    3.5 Epigenetics Drugs and Diagnostic Technologies Key Players Head office and Area Served
    3.6 Key Players Epigenetics Drugs and Diagnostic Technologies Product Solution and Service
    3.7 Date of Enter into Epigenetics Drugs and Diagnostic Technologies Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Epigenetics Drugs and Diagnostic Technologies Breakdown Data by Type
    4.1 Global Epigenetics Drugs and Diagnostic Technologies Historic Market Size by Type (2017-2022)
    4.2 Global Epigenetics Drugs and Diagnostic Technologies Forecasted Market Size by Type (2023-2028)
5 Epigenetics Drugs and Diagnostic Technologies Breakdown Data by Application
    5.1 Global Epigenetics Drugs and Diagnostic Technologies Historic Market Size by Application (2017-2022)
    5.2 Global Epigenetics Drugs and Diagnostic Technologies Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Epigenetics Drugs and Diagnostic Technologies Market Size (2017-2028)
    6.2 North America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2017-2022)
    6.3 North America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Epigenetics Drugs and Diagnostic Technologies Market Size (2017-2028)
    7.2 Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2017-2022)
    7.3 Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size (2017-2028)
    8.2 Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2017-2022)
    8.3 Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Epigenetics Drugs and Diagnostic Technologies Market Size (2017-2028)
    9.2 Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2017-2022)
    9.3 Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size (2017-2028)
    10.2 Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2017-2022)
    10.3 Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Varlix Plc
        11.1.1 Varlix Plc Company Detail
        11.1.2 Varlix Plc Business Overview
        11.1.3 Varlix Plc Epigenetics Drugs and Diagnostic Technologies Introduction
        11.1.4 Varlix Plc Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.1.5 Varlix Plc Recent Development
    11.2 Topotarget
        11.2.1 Topotarget Company Detail
        11.2.2 Topotarget Business Overview
        11.2.3 Topotarget Epigenetics Drugs and Diagnostic Technologies Introduction
        11.2.4 Topotarget Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.2.5 Topotarget Recent Development
    11.3 Syndax Pharmaceuticals
        11.3.1 Syndax Pharmaceuticals Company Detail
        11.3.2 Syndax Pharmaceuticals Business Overview
        11.3.3 Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Introduction
        11.3.4 Syndax Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.3.5 Syndax Pharmaceuticals Recent Development
    11.4 Spectrum Pharmaceuticals
        11.4.1 Spectrum Pharmaceuticals Company Detail
        11.4.2 Spectrum Pharmaceuticals Business Overview
        11.4.3 Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Introduction
        11.4.4 Spectrum Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.4.5 Spectrum Pharmaceuticals Recent Development
    11.5 Promega
        11.5.1 Promega Company Detail
        11.5.2 Promega Business Overview
        11.5.3 Promega Epigenetics Drugs and Diagnostic Technologies Introduction
        11.5.4 Promega Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.5.5 Promega Recent Development
    11.6 Novartis
        11.6.1 Novartis Company Detail
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Epigenetics Drugs and Diagnostic Technologies Introduction
        11.6.4 Novartis Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.6.5 Novartis Recent Development
    11.7 Oncolys BioPharma
        11.7.1 Oncolys BioPharma Company Detail
        11.7.2 Oncolys BioPharma Business Overview
        11.7.3 Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Introduction
        11.7.4 Oncolys BioPharma Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.7.5 Oncolys BioPharma Recent Development
    11.8 MDxHealth
        11.8.1 MDxHealth Company Detail
        11.8.2 MDxHealth Business Overview
        11.8.3 MDxHealth Epigenetics Drugs and Diagnostic Technologies Introduction
        11.8.4 MDxHealth Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.8.5 MDxHealth Recent Development
    11.9 Merck
        11.9.1 Merck Company Detail
        11.9.2 Merck Business Overview
        11.9.3 Merck Epigenetics Drugs and Diagnostic Technologies Introduction
        11.9.4 Merck Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.9.5 Merck Recent Development
    11.10 Illumina
        11.10.1 Illumina Company Detail
        11.10.2 Illumina Business Overview
        11.10.3 Illumina Epigenetics Drugs and Diagnostic Technologies Introduction
        11.10.4 Illumina Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.10.5 Illumina Recent Development
    11.11 Epizyme
        11.11.1 Epizyme Company Detail
        11.11.2 Epizyme Business Overview
        11.11.3 Epizyme Epigenetics Drugs and Diagnostic Technologies Introduction
        11.11.4 Epizyme Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.11.5 Epizyme Recent Development
    11.12 Forum Pharmaceuticals
        11.12.1 Forum Pharmaceuticals Company Detail
        11.12.2 Forum Pharmaceuticals Business Overview
        11.12.3 Forum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Introduction
        11.12.4 Forum Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.12.5 Forum Pharmaceuticals Recent Development
    11.13 EpiGentek
        11.13.1 EpiGentek Company Detail
        11.13.2 EpiGentek Business Overview
        11.13.3 EpiGentek Epigenetics Drugs and Diagnostic Technologies Introduction
        11.13.4 EpiGentek Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.13.5 EpiGentek Recent Development
    11.14 Chroma Therapeutics
        11.14.1 Chroma Therapeutics Company Detail
        11.14.2 Chroma Therapeutics Business Overview
        11.14.3 Chroma Therapeutics Epigenetics Drugs and Diagnostic Technologies Introduction
        11.14.4 Chroma Therapeutics Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.14.5 Chroma Therapeutics Recent Development
    11.15 Celleron Therapeutics
        11.15.1 Celleron Therapeutics Company Detail
        11.15.2 Celleron Therapeutics Business Overview
        11.15.3 Celleron Therapeutics Epigenetics Drugs and Diagnostic Technologies Introduction
        11.15.4 Celleron Therapeutics Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.15.5 Celleron Therapeutics Recent Development
    11.16 CellCentric
        11.16.1 CellCentric Company Detail
        11.16.2 CellCentric Business Overview
        11.16.3 CellCentric Epigenetics Drugs and Diagnostic Technologies Introduction
        11.16.4 CellCentric Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.16.5 CellCentric Recent Development
    11.17 Astex Pharmaceuticals
        11.17.1 Astex Pharmaceuticals Company Detail
        11.17.2 Astex Pharmaceuticals Business Overview
        11.17.3 Astex Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Introduction
        11.17.4 Astex Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.17.5 Astex Pharmaceuticals Recent Development
    11.18 Acetylon Pharmaceuticals
        11.18.1 Acetylon Pharmaceuticals Company Detail
        11.18.2 Acetylon Pharmaceuticals Business Overview
        11.18.3 Acetylon Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Introduction
        11.18.4 Acetylon Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.18.5 Acetylon Pharmaceuticals Recent Development
    11.19 4SC AG
        11.19.1 4SC AG Company Detail
        11.19.2 4SC AG Business Overview
        11.19.3 4SC AG Epigenetics Drugs and Diagnostic Technologies Introduction
        11.19.4 4SC AG Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.19.5 4SC AG Recent Development
    11.20 Eisai
        11.20.1 Eisai Company Detail
        11.20.2 Eisai Business Overview
        11.20.3 Eisai Epigenetics Drugs and Diagnostic Technologies Introduction
        11.20.4 Eisai Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.20.5 Eisai Recent Development
    11.21 Pharmacyclics
        11.21.1 Pharmacyclics Company Detail
        11.21.2 Pharmacyclics Business Overview
        11.21.3 Pharmacyclics Epigenetics Drugs and Diagnostic Technologies Introduction
        11.21.4 Pharmacyclics Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
        11.21.5 Pharmacyclics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Epigenetics Drugs and Diagnostic Technologies Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of HDAC inhibitors
    Table 3. Key Players of DNMT inhibitors
    Table 4. Global Epigenetics Drugs and Diagnostic Technologies Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Epigenetics Drugs and Diagnostic Technologies Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Epigenetics Drugs and Diagnostic Technologies Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Region (2017-2022)
    Table 8. Global Epigenetics Drugs and Diagnostic Technologies Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Region (2023-2028)
    Table 10. Epigenetics Drugs and Diagnostic Technologies Market Trends
    Table 11. Epigenetics Drugs and Diagnostic Technologies Market Drivers
    Table 12. Epigenetics Drugs and Diagnostic Technologies Market Challenges
    Table 13. Epigenetics Drugs and Diagnostic Technologies Market Restraints
    Table 14. Global Epigenetics Drugs and Diagnostic Technologies Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Players (2017-2022)
    Table 16. Global Top Epigenetics Drugs and Diagnostic Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetics Drugs and Diagnostic Technologies as of 2021)
    Table 17. Ranking of Global Top Epigenetics Drugs and Diagnostic Technologies Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Epigenetics Drugs and Diagnostic Technologies Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Epigenetics Drugs and Diagnostic Technologies Product Solution and Service
    Table 21. Date of Enter into Epigenetics Drugs and Diagnostic Technologies Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share by Type (2017-2022)
    Table 25. Global Epigenetics Drugs and Diagnostic Technologies Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share by Type (2023-2028)
    Table 27. Global Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share by Application (2017-2022)
    Table 29. Global Epigenetics Drugs and Diagnostic Technologies Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share by Application (2023-2028)
    Table 31. North America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Varlix Plc Company Detail
    Table 42. Varlix Plc Business Overview
    Table 43. Varlix Plc Epigenetics Drugs and Diagnostic Technologies Product
    Table 44. Varlix Plc Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 45. Varlix Plc Recent Development
    Table 46. Topotarget Company Detail
    Table 47. Topotarget Business Overview
    Table 48. Topotarget Epigenetics Drugs and Diagnostic Technologies Product
    Table 49. Topotarget Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 50. Topotarget Recent Development
    Table 51. Syndax Pharmaceuticals Company Detail
    Table 52. Syndax Pharmaceuticals Business Overview
    Table 53. Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product
    Table 54. Syndax Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 55. Syndax Pharmaceuticals Recent Development
    Table 56. Spectrum Pharmaceuticals Company Detail
    Table 57. Spectrum Pharmaceuticals Business Overview
    Table 58. Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product
    Table 59. Spectrum Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 60. Spectrum Pharmaceuticals Recent Development
    Table 61. Promega Company Detail
    Table 62. Promega Business Overview
    Table 63. Promega Epigenetics Drugs and Diagnostic Technologies Product
    Table 64. Promega Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 65. Promega Recent Development
    Table 66. Novartis Company Detail
    Table 67. Novartis Business Overview
    Table 68. Novartis Epigenetics Drugs and Diagnostic Technologies Product
    Table 69. Novartis Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 70. Novartis Recent Development
    Table 71. Oncolys BioPharma Company Detail
    Table 72. Oncolys BioPharma Business Overview
    Table 73. Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Product
    Table 74. Oncolys BioPharma Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 75. Oncolys BioPharma Recent Development
    Table 76. MDxHealth Company Detail
    Table 77. MDxHealth Business Overview
    Table 78. MDxHealth Epigenetics Drugs and Diagnostic Technologies Product
    Table 79. MDxHealth Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 80. MDxHealth Recent Development
    Table 81. Merck Company Detail
    Table 82. Merck Business Overview
    Table 83. Merck Epigenetics Drugs and Diagnostic Technologies Product
    Table 84. Merck Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 85. Merck Recent Development
    Table 86. Illumina Company Detail
    Table 87. Illumina Business Overview
    Table 88. Illumina Epigenetics Drugs and Diagnostic Technologies Product
    Table 89. Illumina Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 90. Illumina Recent Development
    Table 91. Epizyme Company Detail
    Table 92. Epizyme Business Overview
    Table 93. Epizyme Epigenetics Drugs and Diagnostic TechnologiesProduct
    Table 94. Epizyme Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 95. Epizyme Recent Development
    Table 96. Forum Pharmaceuticals Company Detail
    Table 97. Forum Pharmaceuticals Business Overview
    Table 98. Forum Pharmaceuticals Epigenetics Drugs and Diagnostic TechnologiesProduct
    Table 99. Forum Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 100. Forum Pharmaceuticals Recent Development
    Table 101. EpiGentek Company Detail
    Table 102. EpiGentek Business Overview
    Table 103. EpiGentek Epigenetics Drugs and Diagnostic TechnologiesProduct
    Table 104. EpiGentek Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 105. EpiGentek Recent Development
    Table 106. Chroma Therapeutics Company Detail
    Table 107. Chroma Therapeutics Business Overview
    Table 108. Chroma Therapeutics Epigenetics Drugs and Diagnostic TechnologiesProduct
    Table 109. Chroma Therapeutics Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 110. Chroma Therapeutics Recent Development
    Table 111. Celleron Therapeutics Company Detail
    Table 112. Celleron Therapeutics Business Overview
    Table 113. Celleron Therapeutics Epigenetics Drugs and Diagnostic TechnologiesProduct
    Table 114. Celleron Therapeutics Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 115. Celleron Therapeutics Recent Development
    Table 116. CellCentric Company Detail
    Table 117. CellCentric Business Overview
    Table 118. CellCentric Epigenetics Drugs and Diagnostic TechnologiesProduct
    Table 119. CellCentric Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 120. CellCentric Recent Development
    Table 121. Astex Pharmaceuticals Company Detail
    Table 122. Astex Pharmaceuticals Business Overview
    Table 123. Astex Pharmaceuticals Epigenetics Drugs and Diagnostic TechnologiesProduct
    Table 124. Astex Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 125. Astex Pharmaceuticals Recent Development
    Table 126. Acetylon Pharmaceuticals Company Detail
    Table 127. Acetylon Pharmaceuticals Business Overview
    Table 128. Acetylon Pharmaceuticals Epigenetics Drugs and Diagnostic TechnologiesProduct
    Table 129. Acetylon Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 130. Acetylon Pharmaceuticals Recent Development
    Table 131. 4SC AG Company Detail
    Table 132. 4SC AG Business Overview
    Table 133. 4SC AG Epigenetics Drugs and Diagnostic TechnologiesProduct
    Table 134. 4SC AG Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 135. 4SC AG Recent Development
    Table 136. Eisai Company Detail
    Table 137. Eisai Business Overview
    Table 138. Eisai Epigenetics Drugs and Diagnostic TechnologiesProduct
    Table 139. Eisai Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 140. Eisai Recent Development
    Table 141. Pharmacyclics Company Detail
    Table 142. Pharmacyclics Business Overview
    Table 143. Pharmacyclics Epigenetics Drugs and Diagnostic TechnologiesProduct
    Table 144. Pharmacyclics Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022) & (US$ Million)
    Table 145. Pharmacyclics Recent Development
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Type: 2021 VS 2028
    Figure 2. HDAC inhibitors Features
    Figure 3. DNMT inhibitors Features
    Figure 4. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Application in 2021 & 2028
    Figure 5. Non coding RNA’s Case Studies
    Figure 6. Micro RNA’s Case Studies
    Figure 7. Histone modifications Case Studies
    Figure 8. DNA methylation Case Studies
    Figure 9. Epigenetics Drugs and Diagnostic Technologies Report Years Considered
    Figure 10. Global Epigenetics Drugs and Diagnostic Technologies Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Epigenetics Drugs and Diagnostic Technologies Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Region: 2021 VS 2028
    Figure 13. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Players in 2021
    Figure 14. Global Top Epigenetics Drugs and Diagnostic Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenetics Drugs and Diagnostic Technologies as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Epigenetics Drugs and Diagnostic Technologies Revenue in 2021
    Figure 16. North America Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Epigenetics Drugs and Diagnostic Technologies Market Share by Country (2017-2028)
    Figure 18. United States Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Epigenetics Drugs and Diagnostic Technologies Market Share by Country (2017-2028)
    Figure 22. Germany Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Share by Region (2017-2028)
    Figure 30. China Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Epigenetics Drugs and Diagnostic Technologies Market Share by Country (2017-2028)
    Figure 38. Mexico Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Share by Country (2017-2028)
    Figure 42. Turkey Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Varlix Plc Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 45. Topotarget Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 46. Syndax Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 47. Spectrum Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 48. Promega Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 49. Novartis Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 50. Oncolys BioPharma Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 51. MDxHealth Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 52. Merck Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 53. Illumina Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 54. Epizyme Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 55. Forum Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 56. EpiGentek Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 57. Chroma Therapeutics Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 58. Celleron Therapeutics Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 59. CellCentric Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 60. Astex Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 61. Acetylon Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 62. 4SC AG Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 63. Eisai Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 64. Pharmacyclics Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Varlix Plc
Topotarget
Syndax Pharmaceuticals
Spectrum Pharmaceuticals
Promega
Novartis
Oncolys BioPharma
MDxHealth
Merck
Illumina
Epizyme
Forum Pharmaceuticals
EpiGentek
Chroma Therapeutics
Celleron Therapeutics
CellCentric
Astex Pharmaceuticals
Acetylon Pharmaceuticals
4SC AG
Eisai
Pharmacyclics
Frequently Asked Questions
Epigenetics Drugs and Diagnostic Technologies report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Epigenetics Drugs and Diagnostic Technologies report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Epigenetics Drugs and Diagnostic Technologies report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Exosomes

Exosomes market is segmented by players, region (country), by Type and by Application. Players, s ... Read More

Expression Vectors

Expression Vectors market is segmented by players, region (country), by Type and by Application.  ... Read More